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Conclusion: The 4.6% of local recurrence rate of PMRT cohort 
registered from 2005 to 2013 was lower than 13.1% (12/92) of 
non-PMRT cohort registered from 1990 to 2000. 
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Purpose or Objective: The aim of our study was to 
determine the impact of nodal status and other prognostic 
factors on clinical outcome of patients with breast cancer 
treated with surgery and adjuvant radiotherapy. 
 
Material and Methods: A total of 774 breast cancer patients 
treated between 2001 and 2013 were retrospectively 
analyzed. Qualitative and quantitative characteristics were 
summarized as frequencies and percentages, average and 
standard deviations. The rates of Overall Survival (OS), 
disease free survival (DFS), and loco-regional recurrence (LR) 
were calculated at 36 and 60 months with the Kaplan-Meier 
method. Multivariate analysis was also performed and a p 
value of 0.05 was considered statistically significant. 
 
Results: We identified 774 patients treated with adjuvant RT 
of which 595 patients (75.4%) without nodal involvement 
(pN0), 118 (14.9%) pN1-3 and 61 (7.75%) with more than 3 
positive lymph nodes (pN>3). In our sample, supra-clavicular 
region was irradiated in 62 patients (13 pN>3, 17 pN1-3, 32 
pN0). Median follow-up was 36 months (range 1-144 months). 
There were 14 cases of LR, of which 13 in pN0 and 1 in pN1-3 
patients. A total of 31 patients developed distant metastases 
(48.4% in pN0, 19.4% in pN1-3, 32.2% in pN>3 group). The 
mortality rate was of 2.8% (68.1% pN0, 18.2% pN1-3 and 
13.6% pN>3). There were no statistically significant 
differences in terms of OS, DFS and MFS among the three 
treatment groups. Multivariate analysis showed that clinical 
outcomes were significantly correlated with margin status (p-
value: 0.00), T-stage (p-value: 0.053), Her2-neu gene 
amplification (p-value: 0.00), Ki-67 (p-value: 0.00) and SCRT 
(p-value:0.00). Variables such as age, surgery, ER and PgR 
expression and grading, were not significant. 
 
Conclusion: In our study we observed higher rates of events 
in pN0 and pN1-3 patients, but none statistically significance 
was demonstrated between pN0, pN1-3 and pN>3 in terms of 
OS, DFS and MFS. Furthermore pN0 was in this experience the 
bigger group and this certainly influenced statistical analysis. 
In breast cancer, nodal status plays a key role both in the 
prognostic evaluation and in the therapeutic choice, and the 
clinical outcome of patients pN1-3 is comparable to pN>3 
patients; so in this group (pN1-3) it is also necessary the 
evaluation of other prognostic factors such as receptor 
status, Ki 67 and surgical margins. Nodal status alone seems 
incapable to really guide treatment choice, with particular 
regard to the SCRT appropriateness.  
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Purpose or Objective: The aim of this study was to evaluate 
treatment related complications and patient satisfaction in 
women with locally advanced breast cancer who received 
post-mastectomy radiation therapy after breast 
reconstruction. 
Material and Methods: Between 2009 and 2014, 65 patients, 
median age 48 years, with locally advanced breast cancer 
who underwent mastectomy with breast reconstruction in the 
same time, received post-mastectomy radiation therapy. Two 
patients received excision of local recurrence, 46 patients 
nipple sparing mastectomy, 10 skin sparing mastectomy and 7 
modified radical mastectomy. Post-mastectomy radiation 
therapy was delivered to the chest wall with a dose of 50 Gy 
in 25 fractions over 5 weeks (57 with 3Dconformal RT and 8 
with tomotherapy). 
 
Results: A patient interrupted radiation therapy to 20 Gy for 
severe acute toxicity with rejection of implants (delayed 
removal of the prosthesis). Acute dermal toxicity G2 for 
erythema, telangiectasia (1 patient) and edema was relieved 
in 26 patients, G1 toxicity in 36 patients, G0 in 2 patients and 
G3 in 1 patient. Two patients in systemic progression were 
not considered for local evaluation. At median follow-up of 
35 months: 43 patients presented late toxicity G1 due to 
hyperpigmentation, edema, periprothetic fibrosis. 7 patients 
referred sense of tension or pain and not satisfaction about 
the final aesthetic result. Two patients presented arm 
lymphedema. Two patients received replacing of the 
implants after 36 months due to contraction, encapsulation, 
dislocation, swelling. 
 
Conclusion: Radiotherapy can be safely delivered after 
breast reconstruction, with a low complication rate and good 
patient satisfaction. Further randomized studies are needed 
to better define the optimal management of breast 
reconstruction and post-mastectomy radiation therapy. 
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Purpose or Objective: The impact of adjuvant therapy on 
the surgical outcomes following breast reconstruction is 
poorly understood. The purpose of this work is to evaluate 
surgical outcomes following autologous and prosthetic 
reconstruction in the setting of post-mastectomy radiation 
therapy (PMRT) and adjuvant chemotherapy. We assessed the 
outcome and complications of irradiated patients in our 
department. 
 
Material and Methods: From May 2015 to July 2015 we 
analyzed acute, late toxicity and cosmetic results of 76 
patients with a median age of 50 ± 10 years undergoing 
mastectomy with immediate recostruction with prosthesis 
(79.7%), autologous technique (7.2%) or expander-implant 
(13%) following adjuvant radiotherapy. 24 patients underwent 
to Nac- Sparing Mastectomy, 10 of witch with periareolar 
pexy. 31 patients underwent to Skin reducing Mastectomy 
and 5 patients to Skin Sparing Mastectomy. The radiotherapy 
dose was 50 Gy to chest wall and supraclavicular limphnodes 
when indicated with 6 MV X-ray delivered with Linac (60pt), 
or with tomotherapy (16pt). 
 
Results: With a median follow-up of 25±24 months utilizing 
RTOG toxicity scale we observed a grade I acute toxicity in 
74.6% of patients, grade II in 6% of patients while in 19.4% of 
patients was not observed any sign of toxicity. Late toxicity 
was not observed in 68.7% of patients while in 28.4% of 
patients a grade I late toxicity was noted. No post-operative 
complications was observed in 62.3% of patients while in 
15.9% a capsular contracture was responsible in 20.3% of 
patients of explantation of prosthesis. None of patients 
developed post-operative skin ulcers. Cosmetic results was 
analyzed with Harvard Scale and was excellent in 4.5% of 
patients, good in 32.8%, fair in 16.4% and poor in 46.3%. The 
chi-test showed no correlation between early or late toxicity 
or cosmetics results with type of surgery (p>0.1). Univariate 
